stella
beta
Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy. — Stella
Recruiting
Back to Melanoma Metastatic trials
Trial locations
(3 sites)
Germany
Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg
Heidelberg University Hospital, Heidelberg
LMU Klinikum, München
View full record on ClinicalTrials.gov